Abstract
Non-Hispanic Black patients diagnosed with prostate cancer between 2014 and 2019 and treated at a comprehensive cancer center were less likely to use tumor-specific genomic testing compared with non-Hispanic White patients. Disparities in the use of precision oncology technologies should be monitored and addressed to ensure equitable cancer care.
©2024 The Authors; Published by the American Association for Cancer Research.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Black or African American / genetics
-
Cancer Care Facilities
-
Ethnicity / genetics
-
Genetic Testing* / methods
-
Genomics
-
Healthcare Disparities / ethnology
-
Humans
-
Male
-
Middle Aged
-
North Carolina / epidemiology
-
Precision Medicine / methods
-
Prostatic Neoplasms* / diagnosis
-
Prostatic Neoplasms* / ethnology
-
Prostatic Neoplasms* / genetics
-
Racial Groups / genetics
-
White / genetics